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ABSTRACT The morphogenetic switching between yeast cells and ﬁlaments (true
hyphae and pseudohyphae) is a key cellular feature required for full virulence in
many polymorphic fungal pathogens, such as Candida albicans. In the recently
emerged yeast pathogen Candida auris, occasional elongation of cells has been re-
ported. However, environmental conditions and genetic triggers for ﬁlament forma-
tion have remained elusive. Here, we report that induction of DNA damage and per-
turbation of replication forks by treatment with genotoxins, such as hydroxyurea,
methyl methanesulfonate, and the clinically relevant fungistatic 5-ﬂuorocytosine,
cause ﬁlamentation in C. auris. The ﬁlaments formed were characteristic of pseudo-
hyphae and not parallel-sided true hyphae. Pseudohyphal growth is apparently sig-
naled through the S phase checkpoint and, interestingly, is Tup1 independent in C.
auris. Intriguingly, the morphogenetic switching capability is strain speciﬁc in C. au-
ris, highlighting the heterogenous nature of the species as a whole.
IMPORTANCE Candida auris is a newly emerged fungal pathogen of humans. This
species was ﬁrst reported in 2009 when it was identiﬁed in an ear infection of a pa-
tient in Japan. However, despite intense interest in this organism as an often
multidrug-resistant fungus, there is little knowledge about its cellular biology. Dur-
ing infection of human patients, fungi are able to change cell shape from ellipsoidal
yeast cells to elongated ﬁlaments to adapt to various conditions within the host or-
ganism. There are different types of ﬁlaments, which are triggered by reactions to
different cues. Candida auris fails to form ﬁlaments when exposed to triggers that
stimulate yeast ﬁlament morphogenesis in other fungi. Here, we show that it does
form ﬁlaments when its DNA is damaged. These conditions might arise when Can-
dida auris cells interact with host immune cells or during growth in certain host tis-
sues (kidney or bladder) or during treatment with antifungal drugs.
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The emergence of novel multidrug-resistant pathogens poses a recurrent globalthreat to health care settings. This is the case for the fungus Candida auris
discovered as a new human pathogen only 10 years ago (1), albeit a retrospective
review of strain collections dated the ﬁrst case back to 1996 (2). Since its ﬁrst identi-
ﬁcation, C. auris has been found across all continents, causing clonal outbreaks in
hospital settings (3). It shows mortality rates in systemic disease close to 50% (4), is one
of the most drug-resistant yeast pathogens (5), and has been described as a skin
colonizer able to undergo nosocomial spread (6), thus becoming a major concern for
medical mycology.
Due to the recent emergence of this pathogen, we are largely ignorant about its
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general biological traits. This lack of fundamental understanding about the origin (7, 8)
and the life cycle of C. auris impedes our capacity to explain its sudden emergence,
rapid global spread, and unique phenotypic characteristics. An example is the lack of
information about its ability to undergo morphogenetic switches as described for other
fungi. In fungi, a morphogenetic switch enables cells to change from growing as
unicellular yeasts to pseudohyphae or true hyphae and can be triggered by a multitude
of environmental factors, such as nutrient limitation, temperature, and pH changes
(reviewed in references 9 to 12). Filamentous growth allows the exploration of new
environments and is considered a virulence trait in pathogenic fungi (reviewed in
references 13 and 14). However, most cues causing ﬁlamentation in the best-studied
and only distantly related pathogen Candida albicans do not induce ﬁlamentous
growth in C. auris (15).
In contrast to growth of true hyphae, pseudohyphal growth has been associated
with a delay in cell cycle progression and the subsequent extension of the apical
growth period (16). Indeed, it has been demonstrated that drugs causing genotoxic
stress, such as hydroxyurea (HU) or methyl methanesulfonate (MMS), trigger S phase
arrest via a cell cycle checkpoint (reviewed in reference 17); this results in pseudohyphal
growth in C. albicans and Saccharomyces cerevisiae (18, 19). The S phase checkpoint is
a surveillance system, which responds to DNA damage or DNA replication fork arrest,
and involves the sensor kinases Mec1 and Tel1, the mediator proteins Rad9 and Mrc1,
and an effector kinase, Rad53. Rad9 acts as the main mediator for the DNA damage
response, whereas Mrc1 functions as a DNA replication arrest responder (17). Once
activated, the S phase checkpoint modulates multiple biological processes, including
the repression of late-ﬁring replication origins, cell cycle progression, the production of
deoxynucleotide triphosphates (dNTPs), the transcription of DNA damage response
genes, and inhibition of homologous recombination. Accordingly, activation of Rad53
triggers pseudohyphal growth since in S. cerevisiae or C. albicans mutants deﬁcient in
this kinase showed a drastic reduction of ﬁlamentation under genotoxic stress condi-
tions (19, 20).
Here, we demonstrate that many, but not all, clinical isolates of C. auris are capable
of pseudohyphal growth when treated with genotoxins such as HU, MMS, or the
clinically relevant fungistatic 5-ﬂuorocytosine (5-FC). Deletion mutants of genes in-
volved in the S phase checkpoint, RAD9 and MRC1, or homologous recombination,
RAD51 and RAD57, allowed us to probe whether a functional S phase checkpoint is
required for ﬁlamentous growth in C. auris. Our work provides the ﬁrst insight into how
genome stability maintenance supports cell growth and proliferation and what triggers
morphogenetic switching in the newly emerged fungal pathogen of humans, C. auris.
RESULTS
C. auris produces pseudohyphae under genotoxic stress. Because the ability to
switch between unicellular and ﬁlamentous forms plays a role in pathogenesis in some
fungi (reviewed in references 11 and 12), we were interested in whether C. auris has the
capability to form ﬁlaments as well. Several conditions which induce hyphal growth in
C. albicans, such as incubation at 37°C and in Lee’s medium at pH 3.5 or pH 6.5, as well
as medium containing serum, isoamyl alcohol, or Bleocin, were tested, but none of
these triggered ﬁlamentous growth in the South Asian (clade I) C. auris strain UACa11
(data not shown) (15). Likewise, growth at 25°C did not produce ﬁlaments as described
previously for a C. auris clinical isolate (21). However, using strain UACa11, we observed
ﬁlamentous growth in the presence of sublethal concentrations of genotoxic drugs
affecting DNA replication progression or inducing DNA damage (HU, MMS, and 5-FC)
(Fig. 1) (see also Fig. S1 in the supplemental material; all supplemental ﬁgures and
tables can be found at https://doi.org/10.6084/m9.ﬁgshare.11378550). HU inhibits the
activity of ribonucleotide reductase (22) and thus induces a depletion of the dNTP pools
(23). MMS creates bulky adducts by alkylating DNA that interferes with fork progression
(24). 5-FC is converted into ﬂuorouracil in the cell and perturbs RNA and DNA biosyn-
thesis (25). The ﬁlaments observed in C. auris show characteristics attributed to pseu-
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dohyphae (9, 11). In contrast to true hyphae, ﬁlaments in C. auris are wider than the
diameter of a yeast cell and do not present parallel sides, septa between neighboring
cells show visible indentations, and actin patches are not accumulating at the growing
tip (Fig. 1). Moreover, nuclear divisions seem to occur at mother-daughter junctions,
but this phenotype is often complicated by nuclear division defects due to the
genotoxin treatments (Fig. 1).
Within 6 to 8 h of growth in yeast extract-peptone-glucose (YPD) medium contain-
ing 100 mM HU, daughter cells started to show hyperpolarized growth. This results in
almost 100% ﬁlamentation after overnight culture (Fig. 1E; see Fig. S1A at the URL
mentioned above), similar to C. albicans (18, 20). In this early ﬁlamentation phase,
FIG 1 Filamentation of Candida auris (UACa11) in the presence of genotoxic drugs. (A) Microscopy
images of C. auris ﬁlamentation after growing strain UACa11 cells on YPD plates with or without the
addition of the indicated drug after 3 days at 30°C. A bright-ﬁeld image is shown on the left, and a
merged ﬂuorescent image (chitin stained by calcoﬂuor white [blue] and DNA stained by SYBR green I
[green]) is shown on the right. (B) Cells grown on YPD plates containing 100 mM HU for 3 days at 30°C
stained for actin using rhodamine-phalloidin (RhoPha) (bottom image). The bright-ﬁeld image is on top.
(C) Details of colonies from strain UACA11 grown on YPD plates in the absence and presence of 100 mM
hydroxyurea (HU) for 6 days at 30°C. Scale bars, 10 mm (left) and 1 mm (right). (D) Lengths of ﬁlaments
of wild-type (UACa11) cells grown in YPD medium containing 100 mM HU, 0.02% MMS, or 5 g/ml 5-FC
for 18 to 20 h at 30°C (n 50 for each replicate). Only cells longer than 6 m were considered ﬁlaments.
The dotted line indicates the average length of 300 yeast cells (wild-type UACa11 grown in YPD medium
for 18 to 20 h at 30°C). *, P 0.05 (by Wilcoxon rank sum test); ns, not signiﬁcant. (E) Microscopy images
of representative ﬁlaments of C. auris UACa11 formed in liquid culture. Cells were stained as described
for panel A. After arrest in G1, cultures were grown for 165 min in YPD medium before the indicated drugs
were added (time point 0 h). Bright-ﬁeld images are shown in the top rows, and ﬂuorescent images are
shown at bottom. Scale bar, 10 m.
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generally one or two nuclei (SYBR green-stained DNA signals) were observed within the
same cell, and occasionally very large, high-intensity or stretched out DNA signals could
be seen (Fig. 1E). After 22 h constrictions at septa became evident throughout the
ﬁlaments, and new buds emerged from seemingly random locations along the ﬁlament;
these cultures contained almost no separated (yeast) cells, indicating a defect in cell
separation as expected for pseudohyphal growth (Fig. 1E; Fig. S1A). Cells were often
multi- or anucleate, suggestive of karyokinesis defects. A similar phenotype was gen-
erated by the addition of 0.02% MMS (Fig. 1E) although the formation of ﬁlaments
occurred more slowly, and the resulting pseudohyphae tended to be shorter and more
irregular than those with HU treatment (Fig. 1D). Moreover, after 22 h in MMS, round
and elongated yeast cells were still present in the cultures. Importantly, the number
and length of ﬁlaments decreased over time when cells were grown on plates con-
taining genotoxins (Fig. S2). This means either that long ﬁlaments might not be
viable and that surviving yeast cells start growing after adapting their checkpoint
or that ﬁlaments bud off yeast cells, which then form a new population. It should
also be kept in mind that drugs could be degraded over time and that after several
days the environment on solid medium containing genotoxic drugs could be less
challenging. Filaments can also be observed without stress, as previously reported
(26), but these are rare and could be explained by sporadic DNA damage (see Fig.
S1A at the URL mentioned above). Strikingly, sporadically giant round cells were
also observed in the presence of genotoxic drugs (Fig. S1A and S2). In accordance
with the cellular phenotype, the colony morphology after 5 to 6 days on solid
medium is rougher when HU is present, lacking the typical smooth-colony appear-
ance (Fig. 1C). This was not true in the presence of MMS or 5-FC, either because
these ﬁlaments were shorter or less abundant or because they were more short-
lived than the ones treated with HU (Fig. S2).
C. auris lacks key genes associated with hyphal growth. Filamentation is a
complex mechanism, usually triggered by environmental conditions, involving hun-
dreds of genes in S. cerevisiae and C. albicans (27–29). Among them is a group of
well-studied key regulators known as hypha-speciﬁc genes (HSGs). Previously, Muñoz
and coworkers reported that some HSGs essential for true hyphal growth, such as ECE1
or HWP1, are absent in the C. auris genome (30). We further explored the presence of
key genes in ﬁlamentation in the C. auris genome (see Table S1 at https://doi.org/10
.6084/m9.ﬁgshare.11378550). Besides ECE1 and HWP1, FLO11, EED1, and HWP2 were
also absent in C. auris. In S. cerevisiae Flo11 is a key factor for pseudohyphal growth in
response to nutrient limitation (31, 32). Intriguingly, in C. albicans, which also lacks
Flo11, Hwp2 seems to cover this function (33). UME6, which codes for a Zn(II)2Cys6
transcription factor involved in ﬁlamentation regulation, is present in Candida species
capable of forming true hyphae (C. albicans, C. tropicalis, and C. dubliniensis) and species
unable to form true hyphae (C. parapsilosis, C. orthopsilosis, and C. lusitaniae). Impor-
tantly, in the latter group of species only the C-terminal Zn(II)2Cys6 domain is well
conserved; this is also true for C. auris (see Fig. S3 at the URL mentioned above).
Tup1 is a transcriptional repressor for ﬁlamentous growth in C. albicans acting on
several HSGs, and tup1Δ strains grow constitutively as true hyphae (34, 35). In a C. auris
tup1Δ strain, no ﬁlaments were observed when cells were grown without stress (Fig. 2).
However, strings of yeast cells were frequently observed, indicating that cells cannot
separate properly. Under genotoxic stress, the tup1Δ mutant formed pseudohyphae
similar to those of the parental strain. Altogether, this suggests that ﬁlamentation in C.
auris is likely regulated differently than that in C. albicans.
C. auris has a functional S phase checkpoint. Genotoxic drugs induce replication
fork perturbations and/or DNA damage, leading to cell cycle arrest by triggering the S
phase checkpoint. Genes encoding S phase checkpoint factors, MEC1 (GenBank acces-
sion number XP_028890424), RAD9 (XP_028889586), MRC1 (XP_028891779), and RAD53
(XP_028891118), and homologous recombination proteins, RAD51 (GenBank accession
number XP_028892133) and RAD57 (KND99929), were found in the C. auris genome
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(see Fig. S4 and S5 and Table S1 at the URL mentioned above). Null mutants of RAD9,
MRC1, RAD51, and RAD57 were obtained by deleting the open reading frames (ORFs) in
the C. auris UACa11 strain (Fig. S6). Unfortunately, three attempts to generate mec1Δ or
rad53Δ null mutants with 300 transformants each were unsuccessful, possibly be-
cause these genes are essential in C. auris. The rad51Δ and rad57Δ strains showed very
similar phenotypes (see Fig. S7 at the URL mentioned above); for detailed analysis we
focused on the rad51Δ strain.
The mutant phenotypes were characterized using sublethal concentrations of var-
ious genotoxic drugs (Fig. 3). None of the mutants showed a conspicuous growth
defect in the absence of genotoxins (Fig. 3). The rad9Δ strain showed sensitivity only to
MMS and Bleocin, indicating a role in responding to double-stranded DNA breaks
(Fig. 3). In contrast, the mrc1Δ strain displayed sensitivity to drugs inducing replication-
associated damage (HU, MMS, and 5-FC) but grew like the parental control strain on
Bleocin (Fig. 3). Growth of rad51Δ was severely affected in the presence of HU and MMS
but only moderately so in the presence of Bleocin, and growth was almost indistin-
guishable from that of the wild type on 5-FC (Fig. 3). These mutant C. auris phenotypes
are similar to the ones observed in the corresponding S. cerevisiae and C. albicans
mutants (20, 36–39). However, Mrc1 seems to play a lesser role in C. auris since in the
other two yeasts mrc1Δ strains were more sensitive to MMS, and in C. albicans this
mutant showed a growth defect even when genotoxic challenges were absent (20,
36–39). Taken together, these results suggest that the S phase checkpoint is conserved
in C. auris, albeit with a somewhat reduced importance of Mrc1.
The S phase checkpoint slows down the cell cycle in response to DNA damage or
DNA replication inhibition. The role of C. auris Rad51, Rad9, and Mrc1 for cell cycle arrest
in response to genotoxic stress was further studied. Wild-type C. auris (UACa11) cultures
can be arrested in G1 by nitrogen starvation; almost 100% of cells grown without a
nitrogen source were arrested in G1 after 7 h and remained in G1 during prolonged
(24 h) starvation (see Fig. S8A at https://doi.org/10.6084/m9.ﬁgshare.11378550). Upon
FIG 2 Microscopic analysis of ﬁlament formation in Candida auris tup1mutant (UACa11 background). (A)
Representative microscopic images of C. auris ﬁlaments after growing tup1Δ cells in YPD broth with or
without the addition of the indicated drug for 18 to 20 h at 30°C (top, bright-ﬁeld images; bottom,
merged ﬂuorescent images showing chitin stained by calcoﬂuor white [blue] and DNA stained by SYBR
green I [green]). Scale bar, 10 m. (B) Length of ﬁlaments observed after growth of wild-type (UACa11)
(n 150) and tup1Δ (n 50) cells in YPD broth containing 100 mM HU for 18 to 20 h at 30°C. Only cells
longer than 6 m were considered ﬁlaments. The dotted line indicates the average length of 300 yeast
cells (wild-type UACa11 grown in YPD for 18 to 20 h at 30°C). ns, not signiﬁcant (Wilcoxon rank sum test).
FIG 3 Candida auris rad9, mrc1, and rad51 mutants show sensitivity to genotoxic drugs. Growth analysis
by spot assays of the wild type (UACa11) and the indicated deletion mutants in the presence and
absence of genotoxic drugs. Ten-fold serial dilutions of C. auris cells were grown on YPD plates
containing the indicated drug for 3 days at 30°C.
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return to favorable growth conditions (YPD), wild-type cultures had a lag phase of2.5
to 3 h (Fig. S8B). Therefore, we grew wild-type and mutant yeast cultures for 165 min
in YPD medium after G1 arrest before we started the experiments (time point 0 h) by
adding 100 mM HU or 0.02% MMS as a genotoxic challenge; no drugs were added for
the control. Cells were harvested at different time points, and the replication status of
the cells was determined by ﬂow cytometry (Fig. 4). Under unperturbed conditions,
wild-type (UACa11), rad9Δ, and rad51Δ cells progressed from G1 to G2 within the ﬁrst
hour after reentering the cell cycle (Fig. 4). This is in line with these mutants showing
wild-type growth in solid medium in the absence of genotoxins (Fig. 3). In mrc1Δ cells
a larger fraction of the cell population was in S phase, which suggests that S phase
might last longer in this mutant, which is similar to results in S. cerevisiae and C. albicans
(20, 40, 41). Intriguingly, in C. auris this does not result in a notable growth defect on
solid medium (Fig. 3).
In the parental wild-type strain, the S phase checkpoint is functional, and in the
presence of HU and MMS cell cycle progression is slower than that under unperturbed
conditions, with a large fraction of cells in S phase between 4 and 6 h (Fig. 4).
Eventually, the checkpoint adapts, and cells move to G2 (Fig. 4). This is also largely true
for rad9Δ and rad51Δ cells in the presence of HU, indicating a minor role in the HU
response (Fig. 4). The mrc1 null mutant behaves differently and shows a slower
progression than the parental strain since after 6 h the majority of cells are still in S
phase (Fig. 4). In the rad51Δ mutant most of the cells were arrested in S phase under
MMS treatment, whereas cell cycle progression in the rad9Δ and mrc1Δ mutants was
similar to that of the parental strain under these conditions (Fig. 4). However, in all the
mutants, but not the wild type, a small population of G1 cells was always present during
genotoxin treatments (Fig. 4). This could mean that some cells never enter the cell cycle
after the G1 arrest or that they escape the S phase checkpoint early on and progress
through the cell cycle to G1 quickly; these possibilities are not mutually exclusive.
Indications that the latter possibility actually occurs are (i) that these G1 populations
grow over time in rad9Δ and mrc1Δ mutants under both genotoxic conditions and (ii)
that it also occurs in the wild type when cells are challenged with MMS. This indicates
that rad9Δ and mrc1Δ cells are indeed defective in the S phase checkpoint. At 22 h the
cycle seems to be partially restored (Fig. 4) though the presence of ﬁlaments and
increased cell death after genotoxic treatment confound the interpretation of this
result. Overall, these results support the idea that a functional S phase checkpoint exists
in C. auris.
The S phase checkpoint is involved in pseudohyphal growth. HU and MMS
treatments induce pseudohyphal growth in C. albicans and S. cerevisiae which is
dependent on activation of the S phase checkpoint because a reduction of ﬁlamenta-
tion was described for strains carrying mutations in the gene coding for the S phase
checkpoint kinase Rad53 (19, 20). The ability of mutant C. auris to produce ﬁlaments
was tested in liquid medium (Fig. 5A; see Fig. S1 at the URL mentioned above) and on
solid medium (Fig. 5B; Fig. S2). As described above, wild-type cells of strain UACa11
form pseudohyphal ﬁlaments upon treatment with various genotoxins (Fig. 1).
C. auris rad9Δ cells grew as yeasts without genotoxic stress and as pseudohyphae in
the presence of HU, similar to growth of the wild type (Fig. 5) and of C. albicans rad9Δ
(20). Filaments formed in C. auris rad9Δ are signiﬁcantly shorter than those of the wild
type. Intriguingly, rad9Δ cells produced ﬁlaments growing in liquid medium containing
MMS (Fig. 5; see Fig. S1 at the URL mentioned above), as observed in the wild-type
parent, but failed to form ﬁlaments on solid medium with MMS even after 2 days (Fig.
S2). That partially contrasts with the situation in C. albicans, where rad9Δ cells were
somewhat compromised for ﬁlamentous growth in response to MMS compared to
those of the wild type but would still form short pseudohyphae (20). After 3 days on
solid medium containing 0.02% MMS, a noticeable fraction of rad9Δ cells became very
large and round (giant cells); most of these giant cells are gone after 7 days of culture
(presumably because giant cells have a low viability) (Fig. S2). These giant cells were
Bravo Ruiz et al.
March/April 2020 Volume 5 Issue 2 e00151-20 msphere.asm.org 6
FIG 4 Cell cycle progression of Candida aurismutants under genotoxic stress. Histograms show cell cycle
proﬁles obtained by ﬂow cytometry of the wild type (UACa11) and the indicated mutant derivatives. Cells,
(Continued on next page)
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also observed in the wild type and other mutants, especially under genotoxic stress,
although at much lower frequency (Fig. S1 and S2), indicating that the lack of Rad9
enhances the production of this cell type.
C. auris mrc1Δ cells were elongated but not fully ﬁlamented after growth of 18 to
20 h in liquid medium without genotoxins, in contrast to the round or oval shape of
wild-type cells (Fig. 5). This differs somewhat from growth of C. albicans where
Mrc1-defective cells displayed pseudohyphal growth without stress (20). However, on
solid medium without genotoxic stress, pseudohyphae were observed in mrc1Δ cells
FIG 4 Legend (Continued)
previously arrested in G1 by nitrogen starvation, were transferred to fresh YPD broth and grown for
165 min at 30°C to restart the cycle before addition of 100 mM HU, 0.02% MMS, or no drug (time point
0 h). Cells were harvested at the indicated time points and DNA stained using SYBR green I. The amount
of DNA is expressed as ﬂuorescence intensity. Approximate positions of G1 and G2 peaks are indicated
with dotted lines.
FIG 5 Microscopic analysis of ﬁlament formation in Candida auris rad9, mrc1, and rad51 mutants
(UACa11 background). (A) Representative microscopy images of C. auris ﬁlaments after growth of
wild-type (UACa11), rad9Δ, mrc1Δ, and rad51Δ cells in YPD broth with or without the addition of the
indicated drug for 18 to 20 h at 30°C. (B) Representative microscopic images of C. auris ﬁlaments after
growth of wild-type (UACa11), rad9Δ,mrc1Δ, and rad51Δ cells on YPD plates containing 100 mM HU after
3 days at 30°C. In panels A and B, bright-ﬁeld images are shown in the left columns, and merged
ﬂuorescent images (chitin stained by calcoﬂuor white [CFW] and DNA stained by SYBR green I) are shown
in the right columns. Scale bar, 10 m. (C) Length of ﬁlaments observed after growth of wild-type
(UACa11) (n 150), rad51Δ (n 50), rad9Δ (n 50), and mrc1Δ (n 50) cells in YPD broth containing
100 mM HU for 18 to 20 h at 30°C. Only cells longer than 6 m were considered ﬁlaments. The dotted
line indicates average length of 300 yeast cells (wild-type UACa11 grown in YPD for 18 to 20 h at 30°C).
*, P 0.05, for results relative to those of the wild type (UACa11) (Wilcoxon rank sum test); ns, not
signiﬁcant. (D) Length of ﬁlaments observed after growth of rad51Δ (n 50) and mrc1Δ (n 50) cells in
YPD medium for 18 to 20 h at 30°C without genotoxic stress. Only cells longer than 6 m were
considered ﬁlaments. The dotted line indicates average length of 300 yeast cells (wild-type UACa11
grown in YPD for 18 to 20 h at 30°C).
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(see Fig. S2 at the URL mentioned above). In the presence of HU or MMS, the phenotype
of the mrc1Δ mutant was almost identical to that of the wild-type parent in both liquid
and solid media.
As observed in rad52Δ and rad51Δ cells in C. albicans (37, 42), a sizeable fraction of
cells in the C. auris rad51Δ mutant showed constitutive pseudohyphal growth under
unstressed conditions (Fig. 5; see Fig. S1 and S2 at the URL mentioned above). The
remainder of the cells showed a yeast phenotype or were somewhat elongated and
often of aberrant shape (e.g., giant cells or very wide and elongated cells). When treated
with HU or MMS, this mutant formed pseudohyphae to a similar extent as the wild type,
but the ﬁlaments tended to be longer (Fig. 5C).
Overall, this suggests a role of the S phase checkpoint in C. auris ﬁlamentous growth
although the involvement of this pathway slightly differs from what has been observed
in C. albicans.
C. auris ﬁlamentation is strain dependent. Strikingly, ﬁlamentation in C. auris was
strain dependent. We tested the ﬁlamentation of 22 different C. auris clinical isolates
(see Table S2 at https://doi.org/10.6084/m9.ﬁgshare.11378550) covering the four major
clades (43) by treatment with HU (Fig. 6; Fig. S9). Among them, different grades of
ﬁlamentation were observed: some strains showed longer ﬁlaments (UACa11 or
UACa24) than others (UACa6 or UACa23); some were straight and thin (UACa11 or
UACa24) or wider and shorter, growing as chains of (elongated) cells (bubbles) (UACa7
or UACa22); some formed aberrant cell shapes more frequently (UACa4 or UACa25). The
clade III strain UACa10 seems to be unable to produce ﬁlaments when treated with
FIG 6 Different degrees of ﬁlamentation in Candida auris clinical isolates. Representative microscopy
images of selected clinical isolates (see Table S2 at https://doi.org/10.6084/m9.ﬁgshare.11378550) after
growth in YPD broth containing 100 mM HU for 18 to 20 h at 30°C. Bright-ﬁeld images are shown in the
left columns, and merged ﬂuorescent images (chitin stained by calcoﬂuor white [CFW] and DNA stained
by SYBR green I) are shown in the right columns. Scale bar, 10 m.
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genotoxins; it tended to produce bigger cells than in those produced under unper-
turbed conditions, however. The grade of ﬁlamentation was not obviously correlated
with a particular clade since isolates from the same clade showed different phenotypes.
To evaluate if these strain-dependent ﬁlamentation phenotypes are due to differ-
ences in cell cycle progression under genotoxic stress, we selected ﬁve strains (UACa10,
UACa11, UACa18, UACa22, and UACa25) representing all four clades and showing
different grades of ﬁlamentation (Fig. 6). As before, these strains were subjected to
nitrogen starvation to arrest them in G1, and after pregrowth in liquid medium for
165 min, genotoxins were added. In the presence of HU, the cell cycle in strains
UACa10, UACa22, and UACa25 progressed 1 h faster than the cell cycle in strain
UACa11 (see Fig. S10 at the URL mentioned above). When UACa25 cells were treated
with MMS, the cell cycle progression in was 2 h faster (Fig. S10). In the slow-growing
clade II isolate UACa18, a fraction of the cell population remained in G1 after MMS
treatment (Fig. S10), which indicates that the restart of the cell cycle after G1 arrest
might be slower in this strain. Although we observed some subtle differences between
the C. auris isolates, these do not explain their substantial differences in ﬁlamentation.
Therefore, we looked for single nucleotide polymorphisms (SNPs) between two
strains from the same clade showing different grades of ﬁlamentation, which might
explain this differential cellular behavior (isolates from different clades are too diverse,
and it would be too difﬁcult to ﬁlter out the noise from these data) (43–45). We selected
two strains from clade I (South Asia), UACa1 and UACa4, with different capabilities of
forming pseudohyphae, which differ by 298 SNPs. Intriguingly, of a total of 99 non-
synonymous SNPs within open reading frames, we found 23 genes with a predicted/
demonstrated role in ﬁlamentation and one hypothetical protein of unknown function
with an SNP causing a premature stop codon in UACa1 (see Table S3 at the URL
mentioned above). Unfortunately, this makes it unfeasible to determine a single target
gene as the reason for the phenotypic differences between these two strains and
suggests that several pathways could be involved in enabling or preventing a particular
strain from forming ﬁlaments under stress conditions.
DISCUSSION
Due to the recent emergence of C. auris, there is a lack of understanding about its
life cycle, which impedes full comprehension of its origin, cellular behavior, and
pathogenic traits. Due to the evolutionary distance to the best-studied Candida species,
C. albicans (30), inferences from research on C. albicans are not transferable to C. auris.
This certainly is the case for the morphological switch between yeast cells and
ﬁlaments. Most cues causing ﬁlamentation in C. albicans do not work in C. auris (15; this
study). Accordingly, several genes essential for ﬁlamentation in C. albicans and S.
cerevisiae, such as EED1, FLO11, HWP1, HWP2, or ECE1 (11, 12) are missing from the C.
auris genome (see Table S1; all supplemental ﬁgures and tables can be found at
https://doi.org/10.6084/m9.ﬁgshare.11378550) (30), and some important regulatory
determinants of ﬁlamentation, such as Ume6, show conspicuous differences between
C. auris and C. albicans (Fig. S3). Accordingly, tup1Δ cells do not trigger constitutive
ﬁlamentation in C. auris (Fig. 2A) as they do in C. albicans (34). However, untreated
tup1Δ cells showed defective cell separation. This phenotype might be due to overex-
pression of HGC1, encoding a G1 cyclin, which controls the expression of septum-
degrading enzymes in C. albicans (46), and its expression is kept off by the repressor
complex Tup1/Nrg1 (47). Altogether, these results indicate that C. auris is incapable of
inducing ﬁlamentous growth under the same stimuli as C. albicans.
However, we observed that genotoxic stress triggers ﬁlamentation in most C. auris
isolates tested (Fig. 1 and 6; see Fig. S9 at the URL mentioned above). These ﬁlaments
displayed characteristics attributed to pseudohyphae (reviewed in references 9 and 11),
as previously described in the presence of HU (48). Indeed, the presence of genotoxic
drugs, such as MMS or HU, also triggers pseudohyphal growth in C. albicans and S.
cerevisiae (18–20, 49, 50).
In fungi, the switch from yeast to ﬁlamentous growth is signaled through the
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mitogen-activated protein kinase (MAPK) and the fungal cyclic AMP (cAMP)-protein
kinase A (PKA) pathways. Additionally, other pathways, such as the sucrose-
nonfermentable (SNF), TOR, Hog1, and Rim101 pH-sensing pathways, inﬂuence ﬁla-
mentation (reviewed in references 11 to 13). This process involves 700 genes for
pseudohypha formation in S. cerevisiae (27, 28) and more than 2,000 genes in C.
albicans ﬁlamentous growth (29). However, mutation of key genes regulating ﬁlamen-
tous growth, such as HGC1, UME6, FLO8, TEC1, NRG1, CPH1 (STE12 in S. cerevisiae), or
EFG1, does not affect HU-induced pseudohypha formation (19, 49, 50). Therefore,
pseudohyphal growth upon genotoxic stress apparently involves, at least partially,
different mechanisms.
Genotoxic drugs can induce a variety of DNA damage types and/or perturbation of
DNA replication forks, thus triggering the S phase checkpoint. As part of the checkpoint
response, the kinase Rad53 is activated, which leads to a temporal cell cycle delay until
the issue is resolved and the cell cycle can continue (reviewed in reference 17). A delay
of the cell cycle in S phase and a subsequent transient arrest in G2/M were observed in
various C. auris strains in the presence of the genotoxic agents HU and MMS (Fig. 4; see
Fig. S10 at the URL mentioned above); this suggests that C. auris has a functional S
phase checkpoint. Furthermore, mutation of the S phase checkpoint genes MRC1 and
RAD9 leads to a defective cell cycle arrest since some cells seem to progress quickly to
G1 under genotoxic stress (Fig. 4), similar to growth of the same C. albicans or S.
cerevisiae mutants (20, 38, 40, 41, 51). Although activation of Rad53 by DNA damage or
perturbed DNA replication forks is sensed differently, both types of DNA lesions possess
the molecular signal that triggers the response: an accumulation of single-stranded
DNA (ssDNA) which acts as a signal for recruiting and later activating Mec1 (52–54).
Homologous recombination is required to repair the DNA lesions generated under
genotoxic stress, and, therefore, Rad51 and Rad52 are required to prevent an excess of
ssDNA (52, 55, 56). Indeed, in C. auris rad51Δ, cells were arrested in S phase during MMS
treatment, which suggests an inability to restore the DNA lesions and, therefore, a
constitutive activation of Rad53. Moreover, similar to the rad9Δ or mrc1Δ strain and in
contrast to the wild type, a fraction of the genotoxin-stressed rad51Δ cell population
seems unable to restart the cell cycle after the G1 arrest or move through the cell cycle
without delay (see above) (Fig. 4). Altogether, our results suggest that, similar to other
ascomycetes, C. auris has fully functional S phase checkpoint and homologous recom-
bination pathways.
Pseudohyphal growth in response to genotoxins is S phase checkpoint dependent
as rad53 mutants in C. albicans or S. cerevisiae and mec1Δ mutants in S. cerevisiae
showed a drastic decrease of ﬁlamentation under genotoxin treatment (19, 20). Simi-
larly, strains defective for RAD9 or MRC1 also showed alterations of morphology in the
presence of genotoxic stress in C. albicans (20). After MMS treatment, a C. albicans
RAD9-defective mutant forms ﬁlaments which are considerably shorter than those in
the wild type. In contrast, ﬁlamentation of a C. auris rad9Δ mutant was not different
from that of the wild type after 24 h of MMS treatment in liquid culture (see Fig. S1B
at the URL mentioned above). However, on plates, fewer pseudohyphae were observed
in the C. auris rad9Δ mutant than in the wild type after long-term exposure to MMS
(2 days), albeit a higher proportion of yeast cells became enlarged in the mutant (Fig.
S1A and S2). This cell enlargement was obvious in, but not restricted to, rad9Δ cells and
could occasionally be observed in the wild type and other mutants, especially in the
presence of MMS (Fig. S1A and S2). In other fungi, the presence of enlarged round cells
has been described as Titan cells in Cryptococcus neoformans (57, 58) or Goliath cells in
C. albicans (59). Further studies will be necessary to elucidate whether these large cells
in C. auris resemble Titan or Goliath cells or are something completely different. Taking
these observations together, this would suggest that in C. albicans Rad9 might control
different or additional HSGs than those controlled by C. auris (see below). The C. auris
mrc1Δ mutant induced, at least partially, pseudohyphal growth in the absence of any
genotoxic stress; otherwise, its growth was indiscernible from that of the wild type
(Fig. 5; Fig. S1 and S2). This result is similar to observations in C. albicans (20, 60).
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Interestingly, a C. albicans SGS1 mutant strain, which fails to activate Rad53 via Mrc1,
forms ﬁlaments under unperturbed conditions (61). As a possible explanation, forma-
tion of DNA double-strand breaks in mrc1Δ strains and the subsequent activation of
Rad53 through Rad9 have been suggested (40, 62). An S phase-independent role,
however, has also been described for Mrc1, regulating the replication initiation
through interaction with Cdc7, a conserved kinase that triggers ﬁring at each
replication origin (63), which regulates the mitotic exit through interaction with
Cdc5 (64). This could explain the ﬁlamentation observed in the mrc1Δ mutant (see
below) and the larger S phase population observed in this mutant under unper-
turbed conditions (Fig. 4). Mutation of homologous recombination genes such as
RAD51, RAD52, MRE11, or RAD50 causes constitutive pseudohypha formation in C.
albicans (37, 42, 61). We observed that deletion of RAD51 and RAD57 also triggered
constitutive pseudohyphal growth in C. auris (Fig. 5; see also Fig. S1, S2, and S7 at
the URL mentioned above).
The S phase checkpoint is a complex process, including several back-up mechanisms
which could explain why MRC1 and RAD9 mutants are still able to arrest the cell cycle
and produce ﬁlaments under genotoxic stress. Indeed, it has been reported that Mrc1
depends on Rad9 to stay activated for a long period and that Rad53 is rapidly but only
transiently activated by Mrc1 in rad9Δ cells and is slowly, but continuously, activated by
Rad9 in the absence of MRC1 (17, 51). Accordingly, the double mutant mrc1Δ rad9Δ
strain is inviable (40, 62). That would explain our observations, under MMS treatment,
that in the short term C. auris rad9Δ produces ﬁlaments, due to activation of Rad53 by
Mrc1; but in the long term, Mrc1 is not able to maintain this activation, and cells lose
their ﬁlamentation phenotype.
Mechanisms involved in pseudohyphal growth in response to S phase checkpoint
activation are not well understood, and further studies will be necessary. However, one
mechanism could involve the constitutive activation of the Clb2-Cdc28 complex by
Rad53 in response to genotoxic stress through the polo kinase Cdc5 (65–67). The
activation of Clb2-Cdc28 prevents the entry into mitosis and the associated switch from
polarized to isotropic growth (68, 69); therefore, cells would be stuck in the apical
growth phase, thus forming ﬁlaments. Hence, mutation of CLB2, CDC28, and CDC5
triggers constitutive pseudohyphal growth in yeasts (49, 70, 71). Furthermore, the cAMP
and MAPK pathways have been implicated in pseudohyphal growth in response to
genotoxic stress via downstream regulators (18, 42, 50, 72). A plausible model for C.
auris is depicted in Fig. 7; our model also takes into account that, in C. auris, constitutive
pseudohyphal growth is triggered by downregulation of HSP90, a heat shock family
protein, which acts as a chaperone and inﬂuences a diverse range of signal transducers
(48). Inhibition of HSP90 induces pseudohyphal growth via cAMP-PKA signaling in an
Efg1-independent way in C. albicans (73), and, interestingly, a direct inhibition of Rad53
by Hsp90 has been observed in S. cerevisiae (74).
During infection, cells may encounter various conditions that lead to cell cycle
arrest, produced either by the host or by other microorganisms cohabiting a given
niche. Switching to ﬁlamentous growth might be advantageous, allowing cells to
escape from such perturbations. However, to our knowledge, ﬁlamentous growth in the
context of pathogenesis and colonization has only been described once in C. auris (21).
This strain recovered from an infected mouse displayed ﬁlamentous growth at tem-
peratures below 25°C. However, none of our strains have developed ﬁlamentation
under these conditions. In any case, there currently are not enough data available for
C. auris infection to fully appreciate the potential role of morphogenetic switching,
which contributes to full virulence in C. albicans (reviewed in references 11, 13, and 14).
The different capacities of different strains to form ﬁlaments (21; this study) and the
plasticity of the C. auris genome (43, 75) are indications of the ﬂexibility and adapt-
ability of this fungus, suggesting that different clinical isolates could use morphoge-
netic switching during different phases of pathogenesis.
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MATERIALS AND METHODS
Yeast strains and culture conditions. Candida strains used in this study are listed in Table S2 in the
supplemental material (all supplemental ﬁgures and tables can be found at https://doi.org/10.6084/m9
.ﬁgshare.11378550). Yeast cells were grown at 30°C on YPD plates (1% yeast extract, 2% mycological
peptone, 2% glucose, 2% agar; Oxoid, Basingstoke, UK) or with shaking at 200 rpm in YPD broth (same
constituents as plates, but without agar). Cell concentrations were determined by measuring the optical
density of the culture at a wavelength of 600 nm (OD600) on an Ultraspec 2000 (Pharmacia Biotech,
Uppsala, Sweden) spectrometer (calibration deﬁned an OD600 of 1 to contain 3 107 C. auris cells/ml).
Spot assays were carried out on YPD agar adding the indicated drug where necessary (Fig. 3; see also
Fig. S7A). Cell concentrations were determined by OD600 after overnight growth in YPD broth, and four
1:10 serial dilutions containing 102 to 105 cells were plated and grown at 30°C for 3 days (unless indicated
otherwise).
For ﬁlament visualization, 1 107 cells were grown for 18 to 20 h in YPD broth, unless indicated
otherwise, with addition of 100 M HU, 0.02% MMS, or 5 g/ml 5-FC. Other potential ﬁlamentation
conditions tested were the following: Lee’s medium at pH 3.5 and pH 6.5 (76); YPD (see above) or RPMI
1640 medium containing 20% fetal calf serum (Sigma-Aldrich Corp., St. Louis, MO); YPD medium at a
temperature of 25, 30, or 37°C; presence of 0.5% isoamyl alcohol in YPD medium; and 25 g/ml Bleocin
in YPD medium. To check ﬁlamentation on solid medium, fresh cells were streaked on YPD plates
containing 100 M HU, 0.02% MMS, or 5 g/ml 5-FC and grown at 30°C for the times indicated (Fig. 1
and 5; see also Fig. S2).
Cell cycle analysis and microscopy. To synchronize cultures in G1, cells were grown in YPD broth
overnight at 30°C and 200 rpm. Then 1 107 cells were washed with sterile water and transferred to
nitrogen starvation conditions (6.7 g/liter yeast nitrogen base [YNB] without amino acids and without
ammonium sulfate [Sigma-Aldrich] and 20 g/liter glucose) and grown at 30°C and 200 rpm. Samples were
harvested by centrifugation (1,000 g, 2 min) and ﬁxed by addition of 70% ethanol (EtOH) at the
indicated time points (Fig. 4; see also Fig. S8 and S10). Cells were stored at 4°C before proceeding to
ﬂow cytometry (see below).
The cell cycle of cells previously arrested in G1 from different C. auris strains in the presence of
genotoxic drugs was determined. For this purpose, 1 107 cells, obtained after growth in YPD broth
overnight at 30°C and 200 rpm, were harvested, washed with sterile water, and transferred to nitrogen
starvation conditions (see above) for 15 to 17 h at 30°C and 200 rpm. Then, 1 108 cells were transferred
FIG 7 Schematic representation S phase checkpoint expected for Candida auris. A working model of the S phase
checkpoint based on results of this study and related literature in yeast is shown. Proteins tested in this study are
in color. Possible S phase checkpoint downstream pathways related to ﬁlamentous growth are connected by
dotted lines. Tup1 is a major negative regulator of ﬁlamentation in C. albicans; ﬁlamentation in C. auris is unaffected
by deletion of TUP1. HSGs, hyphal-speciﬁc genes.
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to 10 ml of fresh YPD broth. To restart the cell cycle, cells were grown for 165 min at 30°C and 200 rpm,
after which 100 mM HU or 0.02% MMS were added (a third culture without any additions served as a
control). Cells were harvested by centrifugation (1,000 g, 2 min)and ﬁxed by addition of 70% ethanol
every hour from 0 to 8 h and at a ﬁnal time point of 22 h. Cells were stored at 4°C before proceeding
to ﬂow cytometry (see below). For ﬂow cytometry, yeast samples were prepared as previously described
(75, 77).
For microscopy, cells were ﬁxed by addition of 1 ml 70% EtOH and incubated for at least 2 h at 4°C.
Fixed cells were pelleted (2 min at 1,000 g) and resuspended in sodium citrate buffer (14.7 g/liter
sodium citrate, pH 7.5). Cells were then treated with RNase A (250 g per 1 107 cells) and proteinase
K (1,000 g per 1 107 cells) for 1 h at 50°C; subsequently, Triton X-100 (Sigma-Aldrich) was added to
a ﬁnal concentration of 0.25%. Cells were stained for DNA (SYBR green I, 1:5000; Sigma-Aldrich) and for
chitin (1 g/ml calcoﬂuor white; Sigma) at 4°C overnight. For time course experiments, the same
samples were used for ﬂow cytometry and microscopy (adding 1 g/ml calcoﬂuor white for microscopy).
Rhodamine-phalloidin staining was carried out as previously described (78) with a few modiﬁcations.
Approximately 1  107 cells from an overnight culture were ﬁxed for 1 h in 4% formaldehyde
(phosphate-buffered saline [PBS] buffered) at room temperature, harvested by centrifugation (2 min at
1,000g), and resuspended in PBS before addition of 10 l of rhodamine-phalloidin (6.6 M in meth-
anol) and 1 l of 4=,6=-diamidino-2-phenylindole (DAPI; 10 g/ml). Samples were incubated in the dark
for 1 h and washed in PBS (2 min, 1,000 g) twice. Finally, cells were resuspended in ProLong Diamond
antifade (Thermo Fisher Scientiﬁc, Waltham, MA).
Fluorescent images were taken on a Zeiss Axio Imager M2 microscope with a Zeiss 503 camera and
analyzed using ZEN 2 blue edition software (Carl Zeiss Microscopy, Jena, Germany). Standard bright-ﬁeld
microscopy was performed on a BX50 microscope (Olympus, Tokyo, Japan) equipped with an Inﬁnity 1
camera (Lumenera, Ottawa, Canada) and analyzed using the Inﬁnity capture software, version 6.5.7
(Lumenera, Ottawa, Canada). Colony morphology was imaged on a Zeiss Stemi 2000-c binocular (Carl
Zeiss Microscopy, Jena, Germany) equipped with an Inﬁnity 1 camera (Lumenera, Ottawa, Canada).
Phenotype quantiﬁcations and ﬁlament length measurements were done from bright-ﬁeld micros-
copy images using the cell counter and the measuring tools included in ImageJ (version 1.47; National
Institutes of Health, Bethesda, MD). Box plots, bar charts, and statistical analysis were done in R (version
3.6.0) (https://www.r-project.org/) using the ggplot2 and the ggpubr libraries in the RStudio environment
(version 1.2.1335; RStudio, Inc., Boston, MA). Kruskal-Wallis and Wilcoxon rank sum tests at an alpha level
of 0.05 were used to identify statistical differences between data sets.
Nucleic acid manipulations. For fast genomic DNA (gDNA) extraction, cells from a single colony
were suspended in 20 mM NaOH, boiled at 100°C for 10 min, and incubated on ice for 10 min. Samples
were then centrifuged (2 min at 1,000 g), and a small amount of supernatant was used for PCRs.
For high-quality gDNA extractions, cells from overnight cultures were harvested (2 min at 1,000 g)
and washed with double-distilled water (ddH2O). After the supernatant was removed, acid-washed glass
beads (Sigma-Aldrich) and DNA extraction buffer (1 M NaCl, 2% Triton x-100, 1 M Tris-HCl, pH 8, 0.5 M
EDTA, 1% SDS) were added. Cells were disrupted in a Vibrax VXR (IKA GmbH & Co. KG, Staufen, Germany)
multitube mixer for 3 min before addition of 1 volume of phenol-chloroform-isoamyl alcohol (25:24:1)
(Sigma-Aldrich). Samples were mixed vigorously and centrifuged (10 min at 12,000 g). The supernatant
was transferred to a fresh reaction tube, and 0.1 volume of 3 M sodium acetate, pH 5.2, and 2 volumes
of ice-cold 100% ethanol were added. After precipitation (30 to 60 min at –20°C), samples were
centrifuged (5 min at 12,000 g) and washed with 70% ethanol. Pellets were airdried and resuspended
in ddH2O, and 5 l of RNase (10 mg/ml) was added, followed by an incubation of 30 to 60 min at 37°C.
A small amount of a 1:10 dilution was used for subsequent PCRs.
Standard PCRs were carried out using DreamTaq PCR Master Mix (Thermo Fisher Scientiﬁc) according
to the manufacturer’s instructions. All primers used in this study (see Table S4 at https://doi.org/10.6084/
m9.ﬁgshare.11378550) were designed using the C. auris reference genome (https://www.ncbi.nlm.nih
.gov/genome/?termtxid498019) and synthesized by Sigma-Aldrich.
Gene deletion constructs and transformation. All gene deletion constructs were ampliﬁed using
Phusion High-Fidelity PCR Master Mix (Thermo Fisher Scientiﬁc) as recommended by the supplier.
Genes were deleted using the nourseothricin resistance marker CaNAT1 ﬂanked by 1.5- to 2-kb
regions of homology to up- and downstream sequences of the target gene. CaNAT1, including TEF
promoter and terminator sequences, was PCR ampliﬁed from pV1025 (79) using oligonucleotides
oUA315 and oUA316 (see Table S4 at the URL mentioned above) and cloned into a BamHI-linearized
pFA6a backbone by NEBuilder DNA Assembly Master Mix (New England BioLabs, Ipswich, MA). The
assembly mix was transformed into NEB 10-beta Escherichia coli cells (New England BioLabs) according
to the manufacturer’s instructions. The resulting plasmid, pALo218, was then used to amplify CaNAT1
with the oligonucleotide oUA353 and oUA354 (Table S4). Up- and downstream homologous regions of
the target gene were PCR ampliﬁed from gDNA of UACa11 (Table S2) using speciﬁc primers for each
target gene (Table S4). The oligonucleotide primers on the 3= end of the upstream region and at the 5=
end of the downstream region include short homologies to the CaNAT1 marker to assemble transfor-
mation cassettes via fusion PCR (80). The three PCR products (CaNAT1 and up- and downstream
homology regions) were combined in roughly equimolar amounts (0.15 pmols) together with Phusion
High-Fidelity PCR Master Mix (Thermo Fisher Scientiﬁc) containing 2.5% dimethyl sulfoxide (DMSO) and
subjected to eight PCR cycles (10 s at 98°C, 30 s at 55°C, and 60 s at 72°C). Nested primers (see Table S4
at the URL mentioned above) under standard PCR conditions were used to amplify the ﬁnal transfor-
mation cassettes.
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Gene deletion constructs were transformed into C. auris strain UACa11 using a protocol developed
for C. albicans (81), with small modiﬁcations. Brieﬂy, cells from a culture grown in YPD medium to
stationary phase were diluted 1:100 into fresh YPD broth and incubated with shaking at 30°C until they
reached mid-exponential phase (OD600 of 0.5 to 0.8). Cells were centrifuged (2 min, 1,000 g), washed
once with ddH2O, and resuspended in 100 mM lithium acetate. Transformation mixtures contained
1 g of DNA of the transformation cassette, 100 g of carrier DNA (herring sperm DNA solution;
Thermo Fisher Scientiﬁc), 37% polyethylene glycol (PEG) 3350, 100 mM lithium acetate, and 1.5 108
C. auris cells. The transformation mixture was incubated overnight (16 to 20 h) at 30°C. After a heat shock
of 15 min at 44°C, cells were pelleted by centrifugation (2 min at 1,500 g), resuspended in YPD
medium, and incubated with shaking for 4 h at 30°C. Cells were then plated onto selective YPD agar
containing 100 g/ml nourseothricin (clonNAT; Werner BioAgents GmbH, Jena, Germany) and incubated
at 30°C until transformants appeared. Gene deletion and correct integration were conﬁrmed by PCR
using primers located within the ORF of the target gene and primers located within and without the
transformation cassette (see Fig. S5 and Table S4 at the URL mentioned above).
In silico analysis. Gene and protein sequences were obtained from the C. auris reference genome
(assembly Cand_auris_B11221_V1) in the NCBI database (https://www.ncbi.nlm.nih.gov/genome/?term
txid498019). Interestingly, RAD57 was not present in this reference genome but could be found in the
draft genome of strain Ci6684 (82). Protein sequences of Candida spp. were obtained from the Candida
Genome Database (http://www.candidagenome.org/) or from Uniprot (https://www.uniprot.org/), and
the Saccharomyces Genome Database (https://www.yeastgenome.org/) served as source for S. cerevisiae
protein sequences. Homology scores of C. auris proteins against C. albicans and S. cerevisiae proteins (E
value, length aligned; identities are shown in Table S1, available at the URL mentioned above) were
generated using the BLAST tools of the Candida or the Saccharomyces Genome Databases. Alignments
were carried out by the MSAprobs method (default settings) using Jalview, version 2.10.5 (83).
For SNP calling, Illumina sequencing reads from two clade I strains (UACa1 and UACa4) were aligned
(Z. K. Ross, N. A. R. Gow, and A. Lorenz, unpublished results) using BWA-MEM, version 0.7.12 (84), and
processed with Samtools, version 0.1.19, view, sort, rmdup, and index (85). SNPs were then detected
using Pilon, version 1.22 (86), ﬁltering the resulting variant call format (VCF) ﬁle for genotype 1/1 only.
Low coverage (less than 10% of mean coverage), ambiguous positions, and deletions were removed. The
reference genome was annotated with Augustus, version 3.3.1 (87), ab initio gene prediction software,
and VCF annotator (http://vcfannotator.sourceforge.net) was used to predict the effect of the SNPs called
on the annotated genes.
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